# The Human Medicines Regulations 2012, Paragraph 29A: Application of the batch testing requirement to relevant EU marketing authorisations, and batch testing of biological medicinal products in the EEA before IP completion day (regulation 60B)

Status: repealed

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/33A/paragraph/29A (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-33A/paragraph-29A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.